These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 25819384

  • 1. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
    Park JS, Lee JS, Kim EY, Jung JY, Kim SK, Chang J, Kim DJ, Lee CY, Jung I, Kim JH, Kim HR, Moon YW, Kim HS, Cho BC, Shim HS.
    Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
    [Abstract] [Full Text] [Related]

  • 2. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
    Kim HR, Kim DJ, Kang DR, Lee JG, Lim SM, Lee CY, Rha SY, Bae MK, Lee YJ, Kim SH, Ha SJ, Soo RA, Chung KY, Kim JH, Lee JH, Shim HS, Cho BC.
    J Clin Oncol; 2013 Feb 20; 31(6):731-7. PubMed ID: 23182986
    [Abstract] [Full Text] [Related]

  • 3. Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.
    Elakad O, Lois AM, Schmitz K, Yao S, Hugo S, Lukat L, Hinterthaner M, Danner BC, von Hammerstein-Equord A, Reuter-Jessen K, Schildhaus HU, Ströbel P, Bohnenberger H.
    Cancer Med; 2020 May 20; 9(10):3574-3583. PubMed ID: 32207251
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer.
    Schultheis AM, Bos M, Schmitz K, Wilsberg L, Binot E, Wolf J, Büttner R, Schildhaus HU.
    Mod Pathol; 2014 Feb 20; 27(2):214-21. PubMed ID: 23887299
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study.
    Lim SH, Sun JM, Choi YL, Kim HR, Ahn S, Lee JY, Lee SH, Ahn JS, Park K, Kim JH, Cho BC, Ahn MJ.
    Cancer; 2016 Oct 20; 122(19):3024-31. PubMed ID: 27315356
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic value of fibroblast growth factor receptor 1 gene locus amplification in resected lung squamous cell carcinoma.
    Craddock KJ, Ludkovski O, Sykes J, Shepherd FA, Tsao MS.
    J Thorac Oncol; 2013 Nov 20; 8(11):1371-7. PubMed ID: 24077455
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer.
    Thomas A, Lee JH, Abdullaev Z, Park KS, Pineda M, Saidkhodjaeva L, Miettinen M, Wang Y, Pack SD, Giaccone G.
    J Thorac Oncol; 2014 Apr 20; 9(4):567-71. PubMed ID: 24736083
    [Abstract] [Full Text] [Related]

  • 10. Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.
    Langer CJ, Albert I, Ross HJ, Kovacs P, Blakely LJ, Pajkos G, Somfay A, Zatloukal P, Kazarnowicz A, Moezi MM, Schreeder MT, Schnyder J, Ao-Baslock A, Pathak AK, Berger MS, GEM017 Investigators.
    Lung Cancer; 2014 Sep 20; 85(3):420-8. PubMed ID: 24997137
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.
    Preusser M, Berghoff AS, Berger W, Ilhan-Mutlu A, Dinhof C, Widhalm G, Dieckmann K, Wöhrer A, Hackl M, von Deimling A, Streubel B, Birner P.
    Lung Cancer; 2014 Jan 20; 83(1):83-9. PubMed ID: 24183471
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
    Kim HC, Song JS, Lee JC, Lee DH, Kim SW, Lee JS, Kim WS, Rho JK, Kim SY, Choi CM.
    Int J Clin Exp Pathol; 2014 Jan 20; 7(10):6743-51. PubMed ID: 25400754
    [Abstract] [Full Text] [Related]

  • 14. Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer.
    Yang F, Gao Y, Geng J, Qu D, Han Q, Qi J, Chen G.
    Int J Clin Exp Pathol; 2013 Jan 20; 6(12):2846-54. PubMed ID: 24294370
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.
    Seo AN, Jin Y, Lee HJ, Sun PL, Kim H, Jheon S, Kim K, Lee CT, Chung JH.
    Virchows Arch; 2014 Nov 20; 465(5):547-58. PubMed ID: 25086725
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer.
    Kim KB, Kim Y, Rivard CJ, Kim DW, Park KS.
    Cancer Res; 2020 Nov 15; 80(22):5051-5062. PubMed ID: 32973083
    [Abstract] [Full Text] [Related]

  • 19. FGFR1 amplification in squamous cell carcinoma of the lung.
    Heist RS, Mino-Kenudson M, Sequist LV, Tammireddy S, Morrissey L, Christiani DC, Engelman JA, Iafrate AJ.
    J Thorac Oncol; 2012 Dec 15; 7(12):1775-1780. PubMed ID: 23154548
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.